Overview

Study of Teriparatide in Stress Fracture Healing

Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
Investigation into the use of teriparatide in the treatment of stress fractures. Primary outcome is healing on MRI, secondary outcomes are pain, time spent in rehabilitation and future stress fractures. This study will help the investigators understand how to treat stress fractures in the future.
Phase:
Phase 3
Details
Lead Sponsor:
University of East Anglia
Collaborators:
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
Darlington Memorial Hospital
Ministry of Defence, United Kingdom
Treatments:
Teriparatide